Allan JN, Shanafelt T, Wiestner A, Moreno C, et al. Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials. Br J Haematol 2022;196:947-953.
PMID: 34865212